{ Medical Communication }
Professional writing makes the difference in regulatory submission documents
DaVita Clinical Research’s (DCR) Medical Communication team provides high quality regulatory and commercialization writing for the pharmaceutical and biotech industry. We execute clear, concise, and accurate finished products including protocols, study reports, and manuscripts. Our Medical Communication team provides project management support and quality control of the content to ensure the approval process for each document is efficient and timely.
Our team offers both regulatory and publication editing/writing experience, not only in the area of nephrology, but in areas of nutrition, women’s health, ophthalmology, cardiovascular, and internal medicine.
The Medical Communication team at DCR supports our mission of “advancing the knowledge and practice of kidney care” through the preparation of leading research, investigations, and studies for publication.
Our objectives:
-
Disseminate new knowledge and practices to the healthcare community
-
Test new knowledge in the broader community to ensure the validity of the thought process and determine conclusions
-
Create public awareness of what is being investigated and/or studied
-
Acknowledge participation of patients and healthcare providers
-
Provide opportunities for peer review and discussion
We follow a strict publication policy in line with International Committee of Medical Journal Editors (ICMJE) guidelines, promoting authorship of collaborative research, both internal and external, to DaVita Clinical Research.
Contact DCR’s Medical Communication team at researchandpublishing@davita.com for successful support of your publication continuum from regulatory submission to commercialization writing.
